ERBB2 and breast cancer: The ddPCR results summarized in Figure 2A demonstrated HR CN loss in all four subtypes, with a relative low frequency in the luminal A subtype and a high frequency in the HER2-enriched subtype, largely consistent with the observation of HR CN loss in human BC cell lines.